Table 2 Recurrences between supervised and unsupervised treatment groups with 180-day follow-up period
Total | Supervised | Unsupervised | P | |
|---|---|---|---|---|
n = 117 | n = 56 (47.8%) | n = 61 (52.2%) | ||
Recurrence in 180 days (n/N) | 32/117 (27%) | 10/56 (18%) | 22/61 (36%) | 0.027 |
Number of recurrences (n/N) | 0.07 | |||
1 | 18/32 (56%) | 8/10 (80%) | 10/22 (46%) | |
≥ 2 | 14/32 (43.8%) | 2/10 (20%) | 12/22 (54%) | |
Time to first recurrence (d) (n/N) | 0.04 | |||
≤ 60 | 6/32 (19%) | 1/10 (10%) | 5/22 (23%) | |
61–90 | 14/32 (44%) | 2/10 (20%) | 12/22 (54%) | |
91–180 | 12/32 (37 %) | 7/10 (70%) | 5/22 (23%) | |